Efficacy trials have shown that antiviral therapy improves the outcomes of patients with chronic HBV infection. However, prospective data regarding the effect of antiviral therapy on the incidence of HCC, especially among patients without cirrhosis, are limited.

READ FULL ARTICLE Curated publisher From Wiley Online Library